126 related articles for article (PubMed ID: 29549749)
1. Charge effects of self-assembled chitosan-hyaluronic acid nanoparticles on inhibiting amyloid β-protein aggregation.
Jiang Z; Dong X; Sun Y
Carbohydr Res; 2018 May; 461():11-18. PubMed ID: 29549749
[TBL] [Abstract][Full Text] [Related]
2. Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid.
Wang W; Liu M; Gao W; Sun Y; Dong X
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55879-55889. PubMed ID: 34786930
[TBL] [Abstract][Full Text] [Related]
3. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
[TBL] [Abstract][Full Text] [Related]
4. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of negatively charged hydrophobic nanoparticles and (-)-epigallocatechin-3-gallate on inhibiting amyloid β-protein aggregation.
Liu H; Yu L; Dong X; Sun Y
J Colloid Interface Sci; 2017 Apr; 491():305-312. PubMed ID: 28049055
[TBL] [Abstract][Full Text] [Related]
6. Positively Charged Chitosan and N-Trimethyl Chitosan Inhibit Aβ40 Fibrillogenesis.
Liu H; Ojha B; Morris C; Jiang M; Wojcikiewicz EP; Rao PP; Du D
Biomacromolecules; 2015 Aug; 16(8):2363-73. PubMed ID: 26125953
[TBL] [Abstract][Full Text] [Related]
7. Complex coacervation of hyaluronic acid and chitosan: effects of pH, ionic strength, charge density, chain length and the charge ratio.
Kayitmazer AB; Koksal AF; Kilic Iyilik E
Soft Matter; 2015 Nov; 11(44):8605-12. PubMed ID: 26406548
[TBL] [Abstract][Full Text] [Related]
8. Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity.
Jiang Z; Dong X; Yan X; Liu Y; Zhang L; Sun Y
Sci Rep; 2018 Feb; 8(1):3505. PubMed ID: 29472606
[TBL] [Abstract][Full Text] [Related]
9. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
Umerska A; Corrigan OI; Tajber L
Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.
Liu Y; Kong M; Cheng XJ; Wang QQ; Jiang LM; Chen XG
Carbohydr Polym; 2013 Apr; 94(1):309-16. PubMed ID: 23544543
[TBL] [Abstract][Full Text] [Related]
11. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.
Rocha S; Thünemann AF; Pereira Mdo C; Coelho M; Möhwald H; Brezesinski G
Biophys Chem; 2008 Sep; 137(1):35-42. PubMed ID: 18625543
[TBL] [Abstract][Full Text] [Related]
12. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
13. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K
ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of low-ordered alzheimer β-amyloid oligomers from dimer to hexamer on self-assembled monolayers.
Zhao J; Wang Q; Liang G; Zheng J
Langmuir; 2011 Dec; 27(24):14876-87. PubMed ID: 22077332
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.
Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G
Nanoscale; 2014 Aug; 6(16):9752-62. PubMed ID: 25004796
[TBL] [Abstract][Full Text] [Related]
18. Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis.
Chan HM; Xiao L; Yeung KM; Ho SL; Zhao D; Chan WH; Li HW
Biomaterials; 2012 Jun; 33(18):4443-50. PubMed ID: 22459190
[TBL] [Abstract][Full Text] [Related]
19. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Son G; Lee BI; Chung YJ; Park CB
Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
[TBL] [Abstract][Full Text] [Related]
20. Molybdenum Disulfide Nanoparticles as Multifunctional Inhibitors against Alzheimer's Disease.
Han Q; Cai S; Yang L; Wang X; Qi C; Yang R; Wang C
ACS Appl Mater Interfaces; 2017 Jun; 9(25):21116-21123. PubMed ID: 28613069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
